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Secondary hypertension is the most frequent form of
hypertension in children. Renovascular disease accounts
for 5–10% of all childhood hypertension and should be
suspected in the presence of severe hypertension found
difﬁcult to manage with medical therapy. Uncontrolled
hypertension can lead to severe target organ damage.
We describe the case of a 13-month-old baby boy with
failure to thrive, recent muscular weakness of the lower
extremities and irritability. Hypertension was detected
and he was admitted to the paediatric intensive care
unit with a refractory hypertensive emergency, despite
multiple antihypertensive therapies. Bilateral renal artery
stenosis was diagnosed through renal angiography and
balloon dilation was performed, leading to lower blood
pressure. He is currently withdrawing from
antihypertensive medication, and slowly gaining weight
and recovering from target organ damage. However,
weakness of the lower extremities persists and he has
been diagnosed with a neurogenic bladder.
BACKGROUND
Hypertension affects 1–5% of children and adoles-
cents.1 2 Unlike adults, whose hypertension is
usually primary, most childhood hypertension is sec-
ondary to an underlying disorder.3–5 Renovascular
hypertension (RVH) disease accounts for 5–10% of
all cases.4 6 7 It is characterised by a lesion that limits
blood ﬂow to one or both kidneys, leading to an
activation of the renin–angiotensin–aldosterone
system (RAAS). RAAS activation results in vasocon-
striction and increase in blood volume, contributing
to hypertension, which is usually serious and difﬁ-
cult to control with medical treatment.4 6 8
Fibromuscular dysplasia corresponds to 60% of all
cases of RVH, with bilateral involvement of the
renal artery in about 53–78%.6
Hypertension can be silent or lead to symptoms
related to target organ damage (hypertensive emer-
gency) such as behavioural changes, neurological
deﬁcits, visual changes or heart or renal failure.5 6 9
Failure to thrive (FTT) is also described in associ-
ation with hypertension.5 10 11
We describe the presentation, diagnosis and man-
agement of a 13-month-old baby boy with severe
RVH and target organ damage secondary to bilat-
eral renal artery stenosis. His neurological signs
were severe and did not improve with blood pres-
sure (BP) control.
CASE PRESENTATION
We report a case of a 13-month-old Caucasian boy,
born from the second pregnancy of a
consanguineous couple (second degree cousins).
The pregnancy was uneventful and with normal
fetal ultrasound scans. The child was born at term,
from caesarean section, with a birth weight of
3000 g. He had normal psychomotor development
and an insigniﬁcant medical history. His father had
recently been diagnosed with essential hyperten-
sion. The child was followed up since he was
9 months old due to FTT, slowing of his linear
growth and recent polyuria and polydipsia.
Physical examination revealed weight and height
below the ﬁfth centile (7 kg and 72 cm, respect-
ively), and weight-for-length below the ﬁfth centile.
The child’s skin was pale, without achromic or
café-au-lait spots, and he had malnutrition signs
including decreased subcutaneous tissue on his but-
tocks and thin hair. Abdominal distension was
present, without palpable masses, hepatomegaly or
murmurs.
Laboratory results showed hypochloraemic alkal-
osis, hypokalaemia, hyponatraemia, hypoalbumi-
naemia and nephrotic proteinuria. Coeliac disease
and cystic ﬁbrosis were excluded. At the age of
13 months, the child was referred and admitted to
the paediatric nephrology department with the
hypothetical diagnosis of atypical hypochloraemic
alkalosis (type III). During the week prior to admis-
sion, he developed muscular weakness of both
lower extremities, with left lower limb paresis, loss
of motor acquisitions and sustained irritability.
During hospitalisation, severe hypertension was
found, with a maximum value of 227/125 mm Hg
(95th centile for age, gender and height: 98/
54 mm Hg). Target organ damage evaluation
showed left ventricular concentric hypertrophy
with normal contractile function (echocardiog-
raphy) and hypertensive retinopathy (fundoscopy).
Cranioencephalic and spine MRI demonstrated
signs of microvascular lesions compatible with
medullary infarction. Given the hypertensive emer-
gency, the child was admitted to the paediatric
intensive care unit for treatment and started on an
intravenous infusion of labetalol (up to 3 mg/kg/h).
Partial BP control occurred in the ﬁrst 24 h of
admission. However, he maintained BP superior to
the 99th centile and a second infusion with sodium
nitroprusside (up to 4 mg/kg/min) needed to be
added. Oral minoxidil, amlodipine, captopril and
atenolol were progressively added to the treatment
with the aim of withdrawal from intravenous infu-
sions. However, the child maintained an elevated
BP despite maximum doses of all oral antihyperten-
sive drugs. Starting the fourth day of admission, he
presented with acute renal failure with a maximum
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urea of 13.4 mmol/L and creatinine of 116 mmol/L (glomerular
ﬁltration rate: 24.8 mL/min/1.73 m2). Furosemide infusion was
added due to anasarca.
Other investigations showed hypochloraemic metabolic alkal-
osis, hyponatraemia (134 mmol/L), hypokalaemia (2.8 mmol/L),
hypercholesterolaemia and hypertriglyceridemia without
hypoalbuminaemia. Urinalysis demonstrated nephrotic protein-
uria, microscopic haematuria and glycosuria, and there was
increased activity of plasmatic renin (>500 mUI/mL with hyper-
aldosteronism (150 pg/mL)). Renal ultrasound revealed a larger
left kidney with an apparent posterior mass and poor
parenchyma-sinus differentiation, conﬁrmed by an abdomino-
pelvic CT scan and MRI. Renal Doppler ultrasound was com-
patible with right renal artery stenosis. A biopsy of the posterior
segment of the left kidney was performed after reasonable BP
control. Anatomopathological examination described a general-
ised obliterans arteriolopathy and chronic interstitial nephritis,
compatible with sustained hypertension. Bilateral renal artery
stenosis was found in the renal angiography with two areas of
preocclusive stenosis of the right renal artery and a stenosis of
the superior branch of the left renal artery (ﬁgure 1). Bilateral
angioplasty with balloon dilation was performed with favour-
able response (ﬁgure 2). A rupture of two collateral branches of
the left renal artery occurred during the procedure, which was
successfully treated by transcatheter embolisation with
microcoils.
High plasmatic levels of renin and aldosterone were measured
within the renal vein (1495 μU/mL and 439 pg/mL, respect-
ively), without a difference between left and right renal veins.
After the procedure, a substantial decrease in BP occurred,
allowing for the suspension of the intravenous infusions a few
hours later. However, the child maintained BP above the 95th
centile, requiring maintenance of the oral prescriptions (amlodi-
pine, minoxidil, captopril and atenolol). An improvement in
irritability and weight recovery occurred during the following
weeks after the procedure. About 6 weeks later, renal Doppler
ultrasound scan revealed worsening of the right renal artery
stenosis and renal artery angiography was repeated. Stenosis nar-
rower than 50% was found and, consequently, dilation was not
performed.
Renal scintigraphy with Tc-99m dimercaptosuccinic acid was
also performed, which revealed parenchymal damage mainly in
the left kidney, with a functional amputation of its posterior
segment. Differential kidney function was 63% (right) vs 37%
(left).
Neurological deﬁcits persisted, with spastic paraparesis of the
inferior limbs and pyramidal signs, probably secondary to
medullary infarction. Proteinuria and haematuria gradually
reduced, with normal values from the 40th day after angioplasty.
Dyslipidaemia resolved on the 17th day after the procedure.
Renin and aldosterone levels also reduced gradually with
normal aldosterone levels returning on the 40th day after angio-
plasty. However, renin levels remained high (183 μU/mL)
4 months after the procedure. Renal function was normal from
the second day after angioplasty.
The child was discharged 43 days later, under treatment with
amlodipine, minoxidil, atenolol and captopril.
OUTCOME AND FOLLOW-UP
The child’s BP gradually reduced, with the majority of evalua-
tions below the 95th centile. He is still medicated with the four
antihypertensive drugs 4 months after the ﬁrst angiography. His
left ventricular hypertrophy and retinopathy are gradually
improving. He is recovering growth and under a rehabilitation
programme with a slight improvement of mobility. A neurogenic
bladder was subsequently found for which he is under treatment
with oxybutynine. He is followed in the nephrology, neurology,
cardiology and ophthalmology outpatient clinics.
DISCUSSION
Renal artery stenosis is a rare but important cause of childhood
hypertension. Early diagnosis is essential because adequate treat-
ment can prevent target organ damage.3 5 In the case described,
RVH diagnosis was late and difﬁcult because of its presentation
with FTT, slowing of linear growth and atypical neurological
signs.
This child had FTT and hypochloraemic alkalosis, which ini-
tially evoked the hypothesis of Bartter or Gitelman syndrome.
These two syndromes can present with hypochloraemic alkal-
osis, hypokalaemia and FTT.12 However, they were less likely
after taking into account the hypertension this child presented
Figure 1 Renal angiography revealing bilateral renal artery stenosis
(arrows).
Figure 2 Bilateral renal artery stenosis solved after angioplasty with
balloon dilation (arrow). A rupture of two collateral branches of the left
renal artery occurred during the procedure, which was successfully
treated by transcatheter embolisation with microcoils (arrowhead).
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and the subsequent diagnosis of bilateral renal artery stenosis.
Cystic ﬁbrosis can also cause FTT. Metabolic alkalosis and elec-
trolyte depletion may also occur in these patients.13 14 Cystic
ﬁbrosis was excluded by a negative sweat test.
RVH has been described as a rare cause of FTT, and probably
occurred in this case, since growth recovery occurred after
improvement of BP levels.5 10 11
High BP values must be conﬁrmed and taken into consider-
ation. Children with severe hypertension can present with
severe neurological signs such as headache, facial palsy, acute
hypertensive encephalopathy or cerebrovascular incidents.5 9 15
In this case, there were behavioural changes (irritability), spastic
paraparesis and neurogenic bladder. The cranioencephalic and
spine MRI showed microvascular lesions compatible with
medullary infarction, which probably occurred due to severe
hypertension. Paraparesis and neurogenic bladder, caused by
medullary infarction, are probably a consequence of vascular
injury and haemodynamic instability due to severe hypertension.
The medullary infarction lesions are the likely origin of this
patient’s neurological deﬁcits (spastic paraparesis and neuro-
genic bladder).
An activation of the RAAS by the damaged kidney probably
occurred, with subsequent hypokalaemia, hypervolaemia and
hypertension. Hypervolaemia led to an activation of the atrial
natriuretic peptide and consequent pressure natriuresis by the
contralateral kidney as well as RAAS inhibition, creating a
vicious cycle. Pressure natriuresis caused a decrease in intravas-
cular volume, stimulating thirst and the release of antidiuretic
hormone. All these mechanisms associated with the sodium
depletion resulting from natriuresis contributed to hyponatrae-
mia. Proteinuria, haematuria and glycosuria can also be
explained by this hyperﬁltration state.16–18 Although a bilateral
stenosis was diagnosed in this case, it is possible that, during the
initial phase, there was a smaller commitment of one of the
kidneys, creating the mechanism described above.
The literature reports limitations of renal Doppler ultrasound
scanning in diagnosing RVH.3 6 7 19 20 In the present case, it
provided the diagnostic suspicion of right renal artery stenosis,
although without identifying bilateral stenosis. Renal angiog-
raphy is the most accurate method for assessment of suspected
RVH and allows for treatment with renal angioplasty during the
same procedure.3 6 Measurement of renal vein renin and aldos-
terone concentrations is also useful to diagnose RVH, especially
when the stenosis is bilateral.6
Regarding pharmacological therapy, ACE inhibitors and
angiotensin receptor blockers must be carefully used since they
provoke efferent glomerular arteriole dilation, thus reducing ﬁl-
tration pressure. In cases with bilateral stenosis, they can induce
an important decline in glomerular ﬁltration rate with subse-
quent acute renal failure, as occurred in this case.6 20 21 Yet, it
was the most effective drug. Renal function should be assessed
frequently when these drugs are used.6 21
Percutaneous renal angioplasty may be the ﬁrst-line interven-
tion to treat childhood RVH, with a cure rate between 22% and
59% and improvement in 22–74%.22–24 Angioplasty results are
also less satisfactory in children than in adults, probably due to
the smaller diameter of the vessel and the higher response of
the immature vasculature to growth factors.8 23 Thus, there is a
higher risk of restenosis, as occurred in this case. Renal artery
stenting in children is controversial and rarely used, since it is
associated with non-negligible restenosis, and its long-term
results are not yet fully known in this age group.6 21 23 24
In this case, percutaneous angioplasty performed during angi-
ography allowed the diagnosis and at the same time enabled
renal artery dilation. An important improvement of BP was
registered, although with sustained need for multiple antihyper-
tensive drugs. Renal artery restenosis occurred, which led to
repeating the procedure.
Surgery is reserved for RVH cases resistant to previously
described treatments.6 With this case report, we intend to
emphasise an unusual RVH presentation with FTT, slowing of
linear growth and atypical neurological signs resulting from
central nervous system damage. Renal angiography was the
decisive diagnostic method and renal artery angioplasty the pref-
erential treatment. However, this child currently has important
neurological deﬁcits and requires multidisciplinary follow-up.
This case highlights the importance of BP measurement in FTT.
Proper management of RVH and prevention of its complications
depend on prompt recognition and treatment.
Learning points
▸ Secondary hypertension is the most common form of
hypertension in childhood. It may be associated with failure
to thrive.
▸ Renovascular disease is an important cause of severe
childhood hypertension.
▸ Renal angiography is the gold standard method for
assessment of suspected renovascular hypertension.
▸ Angioplasty is usually required, as renovascular hypertension
is usually refractory to pharmacological treatment.
▸ Hypertension can lead to severe target organ damage,
which can be difﬁcult to recover even after blood pressure
normalisation.
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